Tonn, Joerg C
Deutsches Konsortium für Translationale Krebsforschung · Ludwig-Maximilians-Universität München
3 papers on CoChatORCID 0009-0004-1756-423X
Most cited papers
- Verified
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Stupp, R., Hegi, M. E., Gorlia, T., Erridge, S. C., Perry, J., Hong, Y.-K., Aldape, K. D., Lhermitte, B., Pietsch, T., Grujicic, D., et al. (2014) · The Lancet Oncology
Glioma Diagnosis and TreatmentPARP inhibition in cancer therapy
Cited by 1,052
- Verified
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?
van den Bent, M. J., French, P. J., Brat, D., Tonn, J. C., Touat, M., Ellingson, B. M., Young, R. J., Pallud, J., von Deimling, A., Sahm, F., et al. (2024) · Neuro-Oncology
Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research
Cited by 88
- Verified
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice
Bakas, S., Vollmuth, P., Galldiks, N., Booth, T. C., Aerts, H. J. W. L., Bi, W. L., Wiestler, B., Tiwari, P., Pati, S., Baid, U., et al. (2024) · The Lancet Oncology
Artificial Intelligence in Healthcare and EducationRadiomics and Machine Learning in Medical Imaging
Cited by 36
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free